Kim, Kyung Min
Kim, Byung-Kun
Lee, Wonwoo
Hwang, Heewon
Heo, Kyoung
Chu, Min Kyung
Funding for this research was provided by:
Korean Neurological Association (KNA-20-MI-13)
National Research Foundation of Korea (2019R1F1A1053841)
Article History
Received: 30 August 2021
Accepted: 20 December 2021
First Online: 10 January 2022
Competing interests
: MKC was a site investigator for a multi-center trial sponsored by Otsuka Korea, Novartis International AG, and Eli Lilly and Company. He worked as an advisory member for Teva and has received lecture honoraria from Allergan Korea, Handok-Teva, and Yuyu Pharmaceutical Company in the past 24 months. He received grants from the Yonsei University College of Medicine (2018-32-0037) and the National Research Foundation of Korea (2019R1F1A1053841). KMK, BK, WL, HH, and KH declare no potential conflict of interest.